Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2008

01-01-2008 | Erratum

Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women

Authors: Martha L. Slattery, Carol Sweeney, Sandra Edwards, Jennifer Herrick, Kathy Baumgartner, Roger Wolff, Maureen Murtaugh, Richard Baumgartner, Anna Giuliano, Tim Byers

Published in: Breast Cancer Research and Treatment | Issue 2/2008

Login to get access

Excerpt

We regret to inform you that we have identified an error in the data on height reported in Table 5 of our manuscript “Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women” printed in Breast Cancer Research and Treatment. The corrected data is presented below. We erroneously reported that Hispanic post-menopausal women with very short stature were at reduced breast cancer risk with greater American Indian ancestry when in factor these women are at increased risk. All other numbers and p values were correctly published.
Table 5
Association of breast cancer with body size in Hispanics by genetic admixture
% Membership population one
Pre/Peri Menopausal
Post-menopausal
<61.7%
>61.7%
<61.7%
>61.7%
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
Height (m)
    ≤1.55
0.72 (0.33, 1.57)
1.40 (0.69, 2.85)
0.89 (0.51, 1.56)
1.96 (1.06, 3.65)
    1.56–1.60
1.00
1.00
1.00
1.00
    >1.60
1.07 (0.53, 2.16)
0.70 (0.34, 1.43)
1.55 (0.88, 2.74)
1.60 (0.82, 3.14)
Metadata
Title
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women
Authors
Martha L. Slattery
Carol Sweeney
Sandra Edwards
Jennifer Herrick
Kathy Baumgartner
Roger Wolff
Maureen Murtaugh
Richard Baumgartner
Anna Giuliano
Tim Byers
Publication date
01-01-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9603-y

Other articles of this Issue 2/2008

Breast Cancer Research and Treatment 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine